Sex-specific mortality in ischaemic heart disease across Western Europe: 2023 Global Burden of Disease

BACKGROUND AND AIMS: Ischaemic heart disease (IHD) mortality has declined across Western Europe, but conventional mortality rates may obscure whether women and men experience comparable outcomes once IHD is present. This study examined sex-specific prevalence-adjusted IHD mortality and risk factor-attributable population case fatality across Western European countries. METHODS: Global Burden of Disease 2023 estimates for IHD mortality and prevalence across Western European countries from 2013 to 2023 were analysed. Population case fatality was calculated as age-standardized mortality divided by age-standardized prevalence (mortality-to-prevalence ratio [MPR]). Risk factor-attributable mortality was normalized to IHD prevalence to derive case-fatality indices (CFIs) for metabolic, behavioural, dietary, and environmental exposures. Sex differences were quantified using women-to-men ratios (WMRs). Substantive disparities were defined by WMR deviation ≥20% from unity with <50% overlap of sex-specific uncertainty intervals. RESULTS: Between 2013 and 2023, IHD age-standardized mortality declined by 15.9% in men and 23.5% in women. The pooled Western Europe MPR decreased, from 2.26% to 2.09% in men and from 2.56% to 2.21% in women. Despite these improvements, substantive female excess in MPR was observed in Austria, France, Greece, Israel, Italy, and Spain, whereas substantive male excess was observed only in Iceland. Risk-specific CFIs showed female excess mainly for metabolic risk, low physical activity, and low fibre intake, whereas male excess was most evident for smoking and sugar-sweetened beverages. CONCLUSIONS: Declining IHD mortality across Western Europe conceals persistent sex-specific differences in population case fatality. Sex-disaggregated MPR and risk-specific CFIs may complement conventional surveillance and identify ecological signals, where declining mortality appears disproportionate to the estimated IHD burden.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2026-11-18
DOI
https://doi.org/10.1093/eurheartj/ehag871
Primary Topic
Healthcare Systems and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sex-specific mortality in ischaemic heart disease across Western Europe: 2023 Global Burden of Disease

Susanna Price, Edina Cenko, Nick P Townsend, Raffaele Bugiardini et al.
4 links
European Heart Journal
Healthcare Systems and Public Health
article

Sex-specific mortality in ischaemic heart disease across Western Europe: 2023 Global Burden of Disease

Susanna Price, Edina Cenko, Nick P Townsend, Raffaele Bugiardini, Cecilia Marianne Linde, Martha Gulati, Chris P Gale, Carolin Lerchenmüller, Olivia Manfrini, Tania Rahaman, Veaceslav Sirbu
article en

Abstract

BACKGROUND AND AIMS: Ischaemic heart disease (IHD) mortality has declined across Western Europe, but conventional mortality rates may obscure whether women and men experience comparable outcomes once IHD is present. This study examined sex-specific prevalence-adjusted IHD mortality and risk factor-attributable population case fatality across Western European countries. METHODS: Global Burden of Disease 2023 estimates for IHD mortality and prevalence across Western European countries from 2013 to 2023 were analysed. Population case fatality was calculated as age-standardized mortality divided by age-standardized prevalence (mortality-to-prevalence ratio [MPR]). Risk factor-attributable mortality was normalized to IHD prevalence to derive case-fatality indices (CFIs) for metabolic, behavioural, dietary, and environmental exposures. Sex differences were quantified using women-to-men ratios (WMRs). Substantive disparities were defined by WMR deviation ≥20% from unity with <50% overlap of sex-specific uncertainty intervals. RESULTS: Between 2013 and 2023, IHD age-standardized mortality declined by 15.9% in men and 23.5% in women. The pooled Western Europe MPR decreased, from 2.26% to 2.09% in men and from 2.56% to 2.21% in women. Despite these improvements, substantive female excess in MPR was observed in Austria, France, Greece, Israel, Italy, and Spain, whereas substantive male excess was observed only in Iceland. Risk-specific CFIs showed female excess mainly for metabolic risk, low physical activity, and low fibre intake, whereas male excess was most evident for smoking and sugar-sweetened beverages. CONCLUSIONS: Declining IHD mortality across Western Europe conceals persistent sex-specific differences in population case fatality. Sex-disaggregated MPR and risk-specific CFIs may complement conventional surveillance and identify ecological signals, where declining mortality appears disproportionate to the estimated IHD burden.

European Heart Journal
Houston Methodist (US), University of Leeds (GB), Karolinska University Hospital (SE), University of Zurich (CH), University Hospital Heidelberg (DE), Karolinska Institutet (SE), University of Bristol (GB), Gender Studies (CZ), Royal Brompton Hospital (GB), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), University Hospital of Zurich (CH), Center for Pediatric Endocrinology Zurich (CH), German Centre for Cardiovascular Research (DE), Imperial College London (GB), University of Bologna (IT)
Good health and well-being, Reduced inequalities
Healthcare Systems and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon